41O Intrinsic Valuation and Fundamental Analysis - Outlook Therapeutics Inc

	Outlook Therapeutics Inc F:41O	US
B	Banco Santander SA BCBA:STD	ES
S	Standard Chartered PLC DUS:STD	UK
H	Halliburton Co XMUN:HAL	US
M	Mega Lifesciences PCL SET:MEGA	TH
P	Public Service Enterprise Group Inc XMUN:PSE	US

Intrinsic Value

The intrinsic value for Outlook Therapeutics Inc (41O) under the Base Case is hidden EUR. Compared with the current market price of 0.79 EUR, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

Wall St target

€3.72

Do our valuations actually work? See backtest results .

41O Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €0.79

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

41O looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 41O usually does or if today's premium is unusual.

See where today’s valuation sits in 41O’s own history and what typically happened over the next 12 months after similar periods.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Outlook Therapeutics Inc.

Explain Valuation